Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-09-05 Sale | 2024-09-05 7:51 pm | Athira Pharma Inc. | ATHA | Gengos Andrew CFO and Chief Business Officer | 1,272 | $0.566 | $720 | 97,532 (Direct) | View |
| 2024-09-05 Sale | 2024-09-05 7:50 pm | Athira Pharma Inc. | ATHA | Lenington Rachel COO and CDO | 2,525 | $0.566 | $1,429 | 20,870 (Direct) | View |
| 2024-09-05 Sale | 2024-09-05 7:49 pm | Athira Pharma Inc. | ATHA | CHURCH KEVIN CHIEF SCIENTIFIC OFFICER | 2,525 | $0.566 | $1,429 | 92,684 (Direct) | View |
| 2024-09-05 Sale | 2024-09-05 7:48 pm | Athira Pharma Inc. | ATHA | Worthington Mark GENERAL COUNSEL | 2,525 | $0.566 | $1,429 | 51,927 (Direct) | View |
| 2024-09-05 Sale | 2024-09-05 7:47 pm | Athira Pharma Inc. | ATHA | Litton Mark James President and CEO | 5,032 | $0.566 | $2,848 | 179,054 (Indirect Direct) | View |
| 2024-06-21 Purchase | 2024-06-25 7:21 pm | Athira Pharma Inc. | ATHA | Romano Kelly A Director | 42,400 | $2.3597 | $100,051 | 80,715 (Direct) | View |
| 2024-01-05 Sale(A) | 2024-02-16 4:40 pm | Athira Pharma Inc. | ATHA | Lenington Rachel COO AND CDO | 2,412 | $2.91 | $7,019 | 13,395 (Direct) | View |
| 2024-01-05 Sale(A) | 2024-02-16 4:38 pm | Athira Pharma Inc. | ATHA | Litton Mark James CEO | 4,820 | $2.91 | $14,026 | 164,086 (Indirect Direct) | View |
| 2024-01-05 Sale(A) | 2024-02-16 4:37 pm | Athira Pharma Inc. | ATHA | Worthington Mark GENERAL COUNSEL | 2,412 | $2.91 | $7,019 | 34,452 (Direct) | View |
| 2024-01-05 Sale(A) | 2024-02-16 4:34 pm | Athira Pharma Inc. | ATHA | Gengos Andrew CFO AND CHIEF BUSINESS OFFICER | 1,208 | $2.91 | $3,515 | 83,804 (Direct) | View |
| 2024-01-05 Sale(A) | 2024-02-16 4:32 pm | Athira Pharma Inc. | ATHA | CHURCH KEVIN CHIEF SCIENTIFIC OFFICER | 2,412 | $2.91 | $7,019 | 80,256 (Direct) | View |
| 2023-01-05 Sale | 2024-01-08 4:42 pm | Athira Pharma Inc. | ATHA | Gengos Andrew See Below | 1,208 | $2.91 | $3,515 | 83,804 (Direct) | View |
| 2024-01-05 Sale | 2024-01-08 4:40 pm | Athira Pharma Inc. | ATHA | Litton Mark James Chief Executive Officer | 4,820 | $2.91 | $14,026 | 164,086 (Indirect Direct) | View |
| 2024-01-05 Sale | 2024-01-08 4:38 pm | Athira Pharma Inc. | ATHA | Worthington Mark General Counsel | 2,412 | $2.91 | $7,019 | 34,452 (Direct) | View |
| 2023-01-05 Sale | 2024-01-08 4:36 pm | Athira Pharma Inc. | ATHA | CHURCH KEVIN Chief Scientific Officer | 2,412 | $2.91 | $7,019 | 80,256 (Direct) | View |
| 2024-01-05 Sale | 2024-01-08 4:35 pm | Athira Pharma Inc. | ATHA | Lenington Rachel Chief Operating Officer | 2,412 | $2.91 | $7,019 | 13,395 (Direct) | View |
| 2023-12-27 Purchase | 2023-12-29 5:24 pm | Athira Pharma Inc. | ATHA | PERCEPTIVE ADVISORS LLC PERCEPTIVE LIFE SCIENCES MASTER FUND LTD EDELMAN JOSEPH Director 10% Owner | 605,686 | $2.4153 | $1,462,895 | 5,402,964 (Indirect) | View |
| 2023-06-07 Purchase | 2023-06-09 5:06 pm | Athira Pharma Inc. | ATHA | Gengos Andrew See Below | 15,000 | $3.4297 | $51,445 | 80,012 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-10-03 Option Award(A) | 2024-10-03 9:50 pm | N/A 2034-10-02 | Athira Pharma Inc. | ATHA | Litton Mark James President and CEO | 325,000 | $0 | 325,000 (Direct) | View |
| 2024-10-01 Option Award | 2024-10-03 7:17 pm | N/A N/A | Athira Pharma Inc. | ATHA | Renninger Robert VP of Finance | 74,154 | $0 | 74,154 (Direct) | View |
| 2024-10-01 Option Award | 2024-10-03 7:13 pm | N/A N/A | Athira Pharma Inc. | ATHA | San Martin Javier CHIEF MEDICAL OFFICER | 280,000 | $0 | 280,000 (Direct) | View |
| 2024-10-01 Option Award | 2024-10-03 7:10 pm | N/A N/A | Athira Pharma Inc. | ATHA | CHURCH KEVIN CHIEF SCIENTIFIC OFFICER | 220,000 | $0 | 220,000 (Direct) | View |
| 2024-10-01 Option Award | 2024-10-03 7:08 pm | N/A N/A | Athira Pharma Inc. | ATHA | Worthington Mark General Counsel and CCO | 220,000 | $0 | 220,000 (Direct) | View |
| 2024-10-03 Option Award | 2024-10-03 7:07 pm | N/A N/A | Athira Pharma Inc. | ATHA | Litton Mark James President and CEO | 650,000 | $0 | 650,000 (Direct) | View |
Ownership | 2024-10-03 7:05 pm | N/A N/A | Athira Pharma Inc. | ATHA | Renninger Robert VP of Finance | 0 | $0 | 291,099 (Direct) | View |
| 2024-05-20 Option Award | 2024-09-05 7:51 pm | N/A N/A | Athira Pharma Inc. | ATHA | Gengos Andrew CFO and Chief Business Officer | 10,000 | $1.34 | 97,532 (Direct) | View |
| 2024-09-03 Option Award | 2024-09-05 7:51 pm | N/A N/A | Athira Pharma Inc. | ATHA | Gengos Andrew CFO and Chief Business Officer | 5,000 | $0 | 97,532 (Direct) | View |
| 2024-09-03 Option Award | 2024-09-05 7:50 pm | N/A N/A | Athira Pharma Inc. | ATHA | Lenington Rachel COO and CDO | 10,000 | $0 | 20,870 (Direct) | View |
| 2024-05-20 Option Award | 2024-09-05 7:49 pm | N/A N/A | Athira Pharma Inc. | ATHA | CHURCH KEVIN CHIEF SCIENTIFIC OFFICER | 4,953 | $1.34 | 92,684 (Direct) | View |
| 2024-09-03 Option Award | 2024-09-05 7:49 pm | N/A N/A | Athira Pharma Inc. | ATHA | CHURCH KEVIN CHIEF SCIENTIFIC OFFICER | 10,000 | $0 | 92,684 (Direct) | View |
| 2024-05-20 Option Award | 2024-09-05 7:48 pm | N/A N/A | Athira Pharma Inc. | ATHA | Worthington Mark GENERAL COUNSEL | 10,000 | $1.34 | 51,927 (Direct) | View |
| 2024-09-03 Option Award | 2024-09-05 7:48 pm | N/A N/A | Athira Pharma Inc. | ATHA | Worthington Mark GENERAL COUNSEL | 10,000 | $0 | 51,927 (Direct) | View |
| 2024-09-03 Option Award | 2024-09-05 7:47 pm | N/A N/A | Athira Pharma Inc. | ATHA | Litton Mark James President and CEO | 20,000 | $0 | 179,054 (Direct) | View |
| 2024-05-24 Option Award | 2024-05-24 7:03 pm | N/A 2034-05-23 | Athira Pharma Inc. | ATHA | Romano Kelly A Director | 20,900 | $0 | 20,900 (Direct) | View |
| 2024-05-24 Option Award | 2024-05-24 7:01 pm | N/A 2034-05-23 | Athira Pharma Inc. | ATHA | EDELMAN JOSEPH Director | 20,900 | $0 | 20,900 (Direct) | View |
| 2024-05-24 Option Award | 2024-05-24 7:00 pm | N/A 2034-05-23 | Athira Pharma Inc. | ATHA | JOHNSON JAMES A Director | 20,900 | $0 | 20,900 (Direct) | View |
| 2024-05-24 Option Award | 2024-05-24 6:58 pm | N/A 2034-05-23 | Athira Pharma Inc. | ATHA | Kosacz Barbara Director | 20,900 | $0 | 20,900 (Direct) | View |
| 2024-05-24 Option Award | 2024-05-24 6:56 pm | N/A 2034-05-23 | Athira Pharma Inc. | ATHA | Panzara Michael A. Director | 20,900 | $0 | 20,900 (Direct) | View |
| 2024-05-24 Option Award | 2024-05-24 6:55 pm | N/A 2034-05-23 | Athira Pharma Inc. | ATHA | PICKERING GRANT Director | 20,900 | $0 | 20,900 (Direct) | View |
| 2024-05-24 Option Award | 2024-05-24 6:54 pm | N/A 2034-05-23 | Athira Pharma Inc. | ATHA | FLUKE JOHN M JR Director | 20,900 | $0 | 20,900 (Direct) | View |
| 2024-04-15 Option Award | 2024-04-16 4:37 pm | N/A 2034-04-14 | Athira Pharma Inc. | ATHA | San Martin Javier CHIEF MEDICAL OFFICER | 400,000 | $0 | 400,000 (Direct) | View |
| 2024-02-15 Option Award | 2024-02-16 5:05 pm | N/A 2034-02-14 | Athira Pharma Inc. | ATHA | Litton Mark James CEO | 650,000 | $0 | 650,000 (Direct) | View |
| 2024-02-14 Option Award | 2024-02-16 5:01 pm | N/A 2034-02-13 | Athira Pharma Inc. | ATHA | Worthington Mark GENERAL COUNSEL | 220,000 | $0 | 220,000 (Direct) | View |
| 2024-02-14 Option Award | 2024-02-16 4:54 pm | N/A 2034-02-13 | Athira Pharma Inc. | ATHA | CHURCH KEVIN CHIEF SCIENTIFIC OFFICER | 220,000 | $0 | 220,000 (Direct) | View |
| 2024-02-14 Option Award | 2024-02-16 4:48 pm | N/A 2034-02-13 | Athira Pharma Inc. | ATHA | Gengos Andrew CFO AND CHIEF BUSINESS OFFICER | 280,000 | $0 | 280,000 (Direct) | View |
| 2024-02-14 Option Award | 2024-02-16 4:46 pm | N/A 2034-02-13 | Athira Pharma Inc. | ATHA | Lenington Rachel COO AND CDO | 300,000 | $0 | 300,000 (Direct) | View |
| 2024-01-04 Option Award(A) | 2024-02-16 4:40 pm | N/A N/A | Athira Pharma Inc. | ATHA | Lenington Rachel COO AND CDO | 10,000 | $0 | 13,395 (Direct) | View |
| 2024-01-04 Option Award(A) | 2024-02-16 4:38 pm | N/A N/A | Athira Pharma Inc. | ATHA | Litton Mark James CEO | 20,000 | $0 | 164,086 (Direct) | View |
| 2024-01-04 Option Award(A) | 2024-02-16 4:37 pm | N/A N/A | Athira Pharma Inc. | ATHA | Worthington Mark GENERAL COUNSEL | 10,000 | $0 | 34,452 (Direct) | View |
| 2023-05-18 Option Award(A) | 2024-02-16 4:37 pm | N/A N/A | Athira Pharma Inc. | ATHA | Worthington Mark GENERAL COUNSEL | 7,767 | $2.41 | 34,452 (Direct) | View |
| 2024-01-04 Option Award(A) | 2024-02-16 4:34 pm | N/A N/A | Athira Pharma Inc. | ATHA | Gengos Andrew CFO AND CHIEF BUSINESS OFFICER | 5,000 | $0 | 83,804 (Direct) | View |
| 2023-11-20 Option Award(A) | 2024-02-16 4:32 pm | N/A N/A | Athira Pharma Inc. | ATHA | CHURCH KEVIN CHIEF SCIENTIFIC OFFICER | 3,397 | $1.34 | 80,256 (Direct) | View |
| 2024-01-04 Option Award(A) | 2024-02-16 4:32 pm | N/A N/A | Athira Pharma Inc. | ATHA | CHURCH KEVIN CHIEF SCIENTIFIC OFFICER | 10,000 | $0 | 80,256 (Direct) | View |
| 2023-05-18 Option Award(A) | 2024-02-16 4:32 pm | N/A N/A | Athira Pharma Inc. | ATHA | CHURCH KEVIN CHIEF SCIENTIFIC OFFICER | 809 | $2.41 | 80,256 (Direct) | View |
| 2024-01-04 Option Award | 2024-01-08 4:45 pm | N/A N/A | Athira Pharma Inc. | ATHA | MOEBIUS HANS Chief Medical Officer | 10,000 | $0 | 91,482 (Direct) | View |
| 2023-01-04 Option Award | 2024-01-08 4:42 pm | N/A N/A | Athira Pharma Inc. | ATHA | Gengos Andrew See Below | 5,000 | $0 | 83,804 (Direct) | View |
| 2024-01-04 Option Award | 2024-01-08 4:40 pm | N/A N/A | Athira Pharma Inc. | ATHA | Litton Mark James Chief Executive Officer | 20,000 | $0 | 164,086 (Direct) | View |
| 2024-01-04 Option Award | 2024-01-08 4:38 pm | N/A N/A | Athira Pharma Inc. | ATHA | Worthington Mark General Counsel | 10,000 | $0 | 34,452 (Direct) | View |
| 2023-05-18 Option Award | 2024-01-08 4:38 pm | N/A N/A | Athira Pharma Inc. | ATHA | Worthington Mark General Counsel | 7,767 | $2.41 | 34,452 (Direct) | View |
| 2023-11-20 Option Award | 2024-01-08 4:36 pm | N/A N/A | Athira Pharma Inc. | ATHA | CHURCH KEVIN Chief Scientific Officer | 3,397 | $1.34 | 80,256 (Direct) | View |
| 2023-01-04 Option Award | 2024-01-08 4:36 pm | N/A N/A | Athira Pharma Inc. | ATHA | CHURCH KEVIN Chief Scientific Officer | 10,000 | $0 | 80,256 (Direct) | View |
| 2023-05-18 Option Award | 2024-01-08 4:36 pm | N/A N/A | Athira Pharma Inc. | ATHA | CHURCH KEVIN Chief Scientific Officer | 809 | $2.41 | 80,256 (Direct) | View |
| 2024-01-04 Option Award | 2024-01-08 4:35 pm | N/A N/A | Athira Pharma Inc. | ATHA | Lenington Rachel Chief Operating Officer | 10,000 | $0 | 13,395 (Direct) | View |